A paradigm shift in diagnosis and treatment innovation for mucinous cystic neoplasms of the liver.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 28 03 2024
accepted: 10 07 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: epublish

Résumé

This study comprehensively explores the clinical characteristics, diagnostic approaches, and treatment methods for liver mucinous cystic neoplasms (MCN). A retrospective analysis was conducted on seven individuals diagnosed with MCN, admitted to the Fifth Medical Center of the PLA General Hospital between October 2016 and May 2023. Preoperative AFP was negative, while CA19-9 was elevated in two cases. Surgical resection was performed for all patients. The patients showed favorable postoperative recovery. Follow-up revealed an excellent overall survival rate, except for one case of invasive carcinoma resulting in tumor recurrence and metastasis 6 months after surgery. MCN poses a diagnostic challenge due to the absence of distinct clinical and radiological features, leading to potential misdiagnosis and inappropriate treatment. Patients with suspected liver cystic diseases should consider the possibility of MCN. Surgical resection has proven to be a practical approach with satisfactory therapeutic outcomes.

Identifiants

pubmed: 39019969
doi: 10.1038/s41598-024-67320-2
pii: 10.1038/s41598-024-67320-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16507

Informations de copyright

© 2024. The Author(s).

Références

Nagtegaal, I. D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 76(2), 182–188 (2020).
doi: 10.1111/his.13975 pubmed: 31433515
Zhang, F. B. et al. Preoperative differential diagnosis between intrahepatic biliary cystadenoma and cystadenocarcinoma: A single-center experience. World J. Gastroenterol. 20(35), 12595–12601 (2014).
doi: 10.3748/wjg.v20.i35.12595 pubmed: 25253963 pmcid: 4168096
Wang, C. et al. Intrahepatic biliary cystadenoma and cystadenocarcinoma: An experience of 30 cases. Dig. Liver Dis. 44(5), 426–431 (2012).
doi: 10.1016/j.dld.2011.11.007 pubmed: 22169273
Seo, J. K. et al. Appropriate diagnosis of biliary cystic tumors: Comparison with atypical hepatic simple cysts. Eur. J. Gastroenterol. Hepatol. 22(8), 989–996 (2010).
doi: 10.1097/MEG.0b013e328337c971 pubmed: 20300006
Xu, M. Y. et al. Clinicopathological characteristics and prognostic factors of intrahepatic biliary cystadenocarcinoma. Chin. Med. J. (Engl.) 128(9), 1177–1183. https://doi.org/10.4103/0366-6999.156108 (2015).
doi: 10.4103/0366-6999.156108 pubmed: 25947400
Ratti, F. et al. Biliary cystadenoma: Short- and long-term outcome after radical hepatic resection. Updat. Surg. 64(1), 13–18. https://doi.org/10.1007/s13304-011-0117-0 (2012).
doi: 10.1007/s13304-011-0117-0
Aziz, H. et al. Management of mucinous cystic neoplasms of the liver. J. Gastrointest. Surg. 27(9), 1963–1970. https://doi.org/10.1007/s11605-023-05709-6 (2023).
doi: 10.1007/s11605-023-05709-6 pubmed: 37221388
Kovacs, M. D., Sheafor, D. H., Burchett, P. F., Picard, M. M. & Hardie, A. D. Differentiating biliary cystadenomas from benign hepatic cysts: Preliminary analysis of new predictive imaging features. Clin Imaging 49, 44–47 (2018).
doi: 10.1016/j.clinimag.2017.10.022 pubmed: 29127876
Arnaoutakis, D. J. et al. Management of biliary cystic tumors: A multi-institutional analysis of a rare liver tumor. Ann. Surg. 261(2), 361–367 (2015).
doi: 10.1097/SLA.0000000000000543 pubmed: 24509187
Soni, S., Pareek, P., Narayan, S. & Varshney, V. Mucinous cystic neoplasm of the liver (MCN-L): A rare presentation and review of the literature. Med. Pharm. Rep. 94, 366–371 (2021).
pubmed: 34430860 pmcid: 8357353
Rizzo, A. et al. Lenvatinib plus pembrolizumab: The next frontier for the treatment of hepatocellular carcinoma. Exp. Opin. Investig. Drugs 31, 371–378 (2022).
doi: 10.1080/13543784.2021.1948532
Guven, D. C. et al. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Front. Mol. Biosci. 9, 1039121 (2022).
doi: 10.3389/fmolb.2022.1039121 pubmed: 36533070 pmcid: 9756377
Rizzo, A. et al. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: The MOUSEION-05 study. Cancer Immunol. Immunother. 72, 1381–1394 (2023).
doi: 10.1007/s00262-023-03366-x pubmed: 36695827 pmcid: 10991194
Sahin, T. K., Rizzo, A., Aksoy, S. & Guven, D. C. Prognostic significance of the royal Marsden hospital (RMH) score in patients with cancer: A systematic review and meta-analysis. Cancers (Basel) 16, 1835 (2024).
doi: 10.3390/cancers16101835 pubmed: 38791914
Kim, H. H., Hur, Y. H., Koh, Y. S., Cho, C. K. & Kim, J. W. Intrahepatic biliary cystadenoma: Is there really an almost exclusively female predominance. World J. Gastroenterol. 17(25), 3073–3074 (2011).
doi: 10.3748/wjg.v17.i25.3073 pubmed: 21799657 pmcid: 3132262
Sang, X. et al. Hepatobiliary cystadenomas and cystadenocarcinomas: A report of 33 cases. Liver Int. 31, 1337–1344 (2011).
doi: 10.1111/j.1478-3231.2011.02560.x pubmed: 21745301
Chen, Y. W. et al. Surgical management of biliary cystadenoma and cystadenocarcinoma of the liver. Genet. Mol. Res. 13, 6383–6390 (2014).
doi: 10.4238/2014.August.25.1 pubmed: 25158256
Soochan, D., Keough, V., Wanless, I. & Molinari, M. Intra and extra-hepatic cystadenoma of the biliary duct. Review of literature and radiological and pathological characteristics of a very rare case. BMJ Case Rep. 2012, bcr0120125497 (2012).
doi: 10.1136/bcr.01.2012.5497 pubmed: 22604197 pmcid: 3339162
Ahmad, Z., Uddin, N., Memon, W., Abdul-Ghafar, J. & Ahmed, A. Intrahepatic biliary cystadenoma mimicking hydatid cyst of liver: A clinicopathologic study of six cases. J. Med. Case Rep. 11(1), 317 (2017).
doi: 10.1186/s13256-017-1481-2 pubmed: 29121977 pmcid: 5680786
Armutlu, A. et al. Hepatic cysts: Reappraisal of the classification, terminology, differential diagnosis, and clinicopathologic characteristics in 258 cases. Am. J. Surg. Pathol. 46(9), 1219–1233 (2022).
doi: 10.1097/PAS.0000000000001930 pubmed: 35778790
Jwa, E. K. & Hwang, S. Clinicopathological features and post-resection outcomes of biliary cystadenoma and cystadenocarcinoma of the liver. Ann. Hepat. Pancreat Surg. 21(3), 107–113 (2017).
doi: 10.14701/ahbps.2017.21.3.107
Choi, H. K. et al. Differential diagnosis for intrahepatic biliary cystadenoma and hepatic simple cyst: Significance of cystic fluid analysis and radiologic findings. J. Clin. Gastroenterol. 44(4), 289–293 (2010).
doi: 10.1097/MCG.0b013e3181b5c789 pubmed: 19770676
Labib, P. L., Aroori, S., Bowles, M., Stell, D. & Briggs, C. Differentiating simple hepatic cysts from mucinous cystic neoplasms: Radiological features, cyst fluid tumour marker analysis and multidisciplinary team outcomes. Dig Surg. 34(1), 36–42 (2017).
doi: 10.1159/000447308 pubmed: 27384180
Yang, Y. et al. Intrahepatic biliary cystadenoma: Confusion, experience, and lessons learned from our center. Front. Oncol 12, 1003885 (2022).
doi: 10.3389/fonc.2022.1003885 pubmed: 36439474 pmcid: 9691461
Fuks, D. et al. Intracystic concentrations of tumour markers for the diagnosis of cystic liver lesions. Br. J. Surg. 101(4), 408–416 (2014).
doi: 10.1002/bjs.9414 pubmed: 24477793
Doussot, A. et al. The accuracy of pre-operative imaging in the management of hepatic cysts. HPB (Oxford) 17(10), 889–895 (2015).
doi: 10.1111/hpb.12443 pubmed: 26227923
Klompenhouwer, A. J. et al. The impact of imaging on the surgical management of biliary cystadenomas and cystadenocarcinomas: A systematic review. HPB (Oxford) 21(10), 1257–1267 (2019).
doi: 10.1016/j.hpb.2019.04.004 pubmed: 31085104
Tatsumi, R. et al. A case of mucinous cystic neoplasm of the liver. Nihon Shokakibyo Gakkai Zasshi 112(7), 1357–1366 (2015).
pubmed: 26155869
Ozaki, K. et al. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Jpn. J. Radiol. 38, 697–718 (2020).
doi: 10.1007/s11604-020-00961-1 pubmed: 32246350
Wang, K., Kong, F., Dong, M., Zhou, J. & Li, Y. Diagnosis and treatment of intrahepatic biliary cystadenoma: Experience with 14 cases in a single center. Med. Oncol. 31(11), 274 (2014).
doi: 10.1007/s12032-014-0274-3 pubmed: 25287908
Romagnoli, R. et al. Liver transplantation for symptomatic centrohepatic biliary cystadenoma. Clin. Res. Hepatol. Gastroenterol. 35(5), 408–413 (2011).
doi: 10.1016/j.clinre.2011.03.014 pubmed: 21549659

Auteurs

Bin Shi (B)

Department of Organ Transplantation, The Third Medical Center of PLA General Hospital, Beijing, China.

Peng Yu (P)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Lingzhan Meng (L)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Hu Li (H)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Zizheng Wang (Z)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Li Cao (L)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Jin Yan (J)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Yanling Shao (Y)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China.

Ying Zhang (Y)

Department of General Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China. zhangyingyh@aliyun.com.

Zhenyu Zhu (Z)

Department of Hepatology Surgery, The Fifth Medical Center of the PLA General Hospital, Beijing, China. zhuzy302@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH